TCEA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.981600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.387200E-01
Normal-vs-Stage2
6.867200E-01
Normal-vs-Stage3
3.073800E-01
Normal-vs-Stage4
4.350600E-01
Stage1-vs-Stage2
8.044400E-01
Stage1-vs-Stage3
4.898600E-01
Stage1-vs-Stage4
7.147200E-01
Stage2-vs-Stage3
5.624600E-01
Stage2-vs-Stage4
8.528200E-01
Stage3-vs-Stage4
6.045200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.719000E-01
Normal-vs-AfricanAmerican
5.984000E-01
Normal-vs-Asian
7.852200E-01
Caucasian-vs-AfricanAmerican
8.406400E-01
Caucasian-vs-Asian
8.659200E-01
AfricanAmerican-vs-Asian
9.750800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.384000E-01
Normal-vs-Female
6.709000E-01
Male-vs-Female
7.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.610440E-01
Normal-vs-Age(41-60Yrs)
6.750800E-01
Normal-vs-Age(61-80Yrs)
7.083400E-01
Normal-vs-Age(81-100Yrs)
9.980800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.454780E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.439000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.045600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.277200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.719000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.321800E-01
Normal-vs-Daily Drinker
8.755800E-01
Normal-vs-Weekly Drinker
1.758780E-01
Normal-vs-Occasional Drinker
8.566600E-01
Normal-vs-Social Drinker
5.371200E-01
Non Drinker-vs-Daily Drinker
4.082200E-01
Non Drinker-vs-Weekly Drinker
3.441600E-01
Non Drinker-vs-Occasional Drinker
6.432200E-02
Non Drinker-vs-Social Drinker
9.181400E-01
Daily Drinker-vs-Weekly Drinker
1.399840E-01
Daily Drinker-vs-Occasional Drinker
5.402400E-01
Daily Drinker-vs-Social Drinker
4.762600E-01
Weekly Drinker-vs-Occasional Drinker
2.120100E-02
Weekly Drinker-vs-Social Drinker
5.415400E-01
Occasional Drinker-vs-Social Drinker
1.507040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.509000E-01
Normal-vs-Grade 2
4.416400E-02
Normal-vs-Grade 3
1.080780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.863800E-01
Grade 1-vs-Grade 3
5.174400E-01
Grade 1-vs-Grade 4
2.509000E-01
Grade 2-vs-Grade 3
3.054400E-01
Grade 2-vs-Grade 4
4.416400E-02
Grade 3-vs-Grade 4
1.080780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.897800E-01
Normal-vs-NonDiabetic
6.449800E-01
Diabetic-vs-NonDiabetic
8.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.361400E-01
Normal-vs-NoPancreatitis
7.084600E-01
Pancreatitis-vs-NoPancreatitis
6.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.254000E-01
Normal-vs-N1
6.906800E-01
N0-vs-N1
5.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.994600E-01
Normal-vs-TP53-NonMutant
5.051000E-01
TP53-Mutant-vs-TP53-NonMutant
2.380400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
